Astellas Pharma Europe B.V.
- B03 - Preparados antianémicos
- EVRENZO film-coated tablet 100 mg
- EVRENZO film-coated tablet 150 mg
- EVRENZO film-coated tablet 20 mg
- EVRENZO film-coated tablet 50 mg
- EVRENZO film-coated tablet 70 mg
- G04 - Urológicos
- BETMIGA prolonged-release tablet 25 mg
- BETMIGA prolonged-release tablet 50 mg
- J02 - Antimicóticos de uso sistémico
- MYCAMINE powder for solution for infusion 100 mg
- MYCAMINE powder for solution for infusion 50 mg
- L01 - Antineoplásicos
- PADCEV powder for solution for infusion 20 mg
- PADCEV powder for solution for infusion 20 mg
- PADCEV powder for solution for infusion 30 mg
- XOSPATA film-coated tablet 40 mg
- L02 - Terapia endocrina
- XTANDI capsule, soft 40 mg
- XTANDI film-coated tablet 40 mg
- XTANDI film-coated tablet 80 mg
- L04 - Inmunosupresores
- ADVAGRAF prolonged-release capsule, hard 0.5 mg
- ADVAGRAF prolonged-release capsule, hard 1 mg
- ADVAGRAF prolonged-release capsule, hard 3 mg
- ADVAGRAF prolonged-release capsule, hard 5 mg
- MODIGRAF granules for oral suspension 0.2 mg
- MODIGRAF granules for oral suspension 1 mg